We are live on
!
Find out more
CPIM
Columbia Partners Investment Management Portfolio holdings
AUM
$257M
1-Year Est. Return
8.17%
This Fund
S&P 500
This Quarter
Est. Return
+3.26%
1 Year Est. Return
+8.17%
3 Year Est. Return
+69.66%
5 Year Est. Return
+127.32%
10 Year Est. Return
–
AUM
$2.16B
AUM Growth
-$131M
(-5.7%)
Cap. Flow
-$154M
Cap. Flow
% of AUM
-7.13%
Top 10 Holdings %
Top 10 Hldgs %
17.1%
Holding
389
New
65
Increased
97
Reduced
166
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GHL
Greenhill & Co., Inc.
GHL
|
+$8.56M |
| 2 |
Visa
V
|
+$7.84M |
| 3 |
SEM
Select Medical
SEM
|
+$7.72M |
| 4 |
EDR
Education Realty Trust Inc
EDR
|
+$7.28M |
| 5 |
WSFS Financial
WSFS
|
+$7.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MasTec
MTZ
|
+$16M |
| 2 |
FNSR
Finisar Corp
FNSR
|
+$15.4M |
| 3 |
Coca-Cola
KO
|
+$12.2M |
| 4 |
FUEL
Rocket Fuel Inc.
FUEL
|
+$11.1M |
| 5 |
AGN
Allergan Inc
AGN
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.81% |
| 2 | Healthcare | 13.9% |
| 3 | Consumer Discretionary | 11.17% |
| 4 | Industrials | 10.85% |
| 5 | Communication Services | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
SLB Ltd
SLB
$78.1B
| $4.51M | 0.21% |
38,267
-17,155
| -31% | -$1.77M |
|
|
SRCL
152
DELISTED
Stericycle Inc
SRCL
| $4.36M | 0.2% |
36,819
-451
| -1% | -$51.6K |
|
153
Amgen
AMGN
$225B
| $4.35M | 0.2% |
36,743
+15,279
| +71% | +$1.77M |
|
154
RTX Corp
RTX
$300B
| $4.23M | 0.2% |
58,242
+34,046
| +141% | +$2.51M |
|
155
AstraZeneca
AZN
$246B
| $4.19M | 0.19% |
56,364
+25,236
| +81% | +$1.82M |
|
156
Terreno Realty
TRNO
$7.48B
| $4.18M | 0.19% |
216,171
+50,143
| +30% | +$941K |
|
|
BNNY
157
DELISTED
ANNIES INC COMMON STOCK (DE)
BNNY
| $4.16M | 0.19% |
123,097
+3,722
| +3% | +$125K |
|
158
Pacira BioSciences
PCRX
$945M
| $4.14M | 0.19% |
+45,108
| New | +$3.43M |
|
|
REN
159
DELISTED
Resolute Energy Corporaton
REN
| $4.14M | 0.19% |
95,894
+3,847
| +4% | +$152K |
|
160
Wolfspeed
WOLF
$1.65B
| $4.05M | 0.19% |
81,064
-1,004
| -1% | -$49.9K |
|
|
VSI
161
DELISTED
Vitamin Shoppe Inc.
VSI
| $4.03M | 0.19% |
93,649
+2,794
| +3% | +$126K |
|
162
UnitedHealth
UNH
$364B
| $3.97M | 0.18% |
48,622
-14,022
| -22% | -$1.1M |
|
|
RDEN
163
DELISTED
ELIZABETH ARDEN INC
RDEN
| $3.97M | 0.18% |
185,447
-104,878
| -36% | -$3.02M |
|
164
Abbott
ABT
$192B
| $3.97M | 0.18% |
97,068
-8,796
| -8% | -$345K |
|
165
GSK
GSK
$101B
| $3.97M | 0.18% |
59,347
+20,165
| +51% | +$1.36M |
|
|
ULTI
166
DELISTED
Ultimate Software Group Inc
ULTI
| $3.95M | 0.18% |
+28,566
| New | +$3.63M |
|
|
BPZ
167
DELISTED
BPZ RESOURCES INC COM STK
BPZ
| $3.87M | 0.18% |
1,256,035
-267,935
| -18% | -$778K |
|
|
OCR
168
DELISTED
OMNICARE INC
OCR
| $3.83M | 0.18% |
57,484
+42,247
| +277% | +$2.63M |
|
|
ENZ
169
DELISTED
Enzo Biochem, Inc.
ENZ
| $3.75M | 0.17% |
714,284
+426,111
| +148% | +$1.84M |
|
170
Aptiv
APTV
$10.1B
| $3.69M | 0.17% |
53,612
-13,193
| -20% | -$895K |
|
171
Colgate-Palmolive
CL
$73.6B
| $3.69M | 0.17% |
54,056
-9,560
| -15% | -$641K |
|
172
Pfizer
PFE
$150B
| $3.65M | 0.17% |
129,701
-108,172
| -45% | -$3.08M |
|
|
DOC
173
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $3.63M | 0.17% |
252,265
-3,881
| -2% | -$53K |
|
174
Novartis
NVS
$290B
| $3.61M | 0.17% |
44,515
+31,545
| +243% | +$2.48M |
|
|
VRNT
175
DELISTED
Verint Systems
VRNT
| $3.52M | 0.16% |
140,790
-2,063
| -1% | -$48.5K |
|
Similar funds
REFI
CHA
VAM
HCG
LA
FIMG
PC
PPC
Columbia Partners Investment Management's Q2 2014 Portfolio in Review
As of Q2 2014, Columbia Partners Investment Management held 389 positions worth $2.16B, down 5.7% from $2.29B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Columbia Partners Investment Management withdrew a net $154M in Q2 2014, closing 55 positions and reducing 166 holdings. Its most notable exit was Rocket Fuel Inc., an estimated $11.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Columbia Partners Investment Management opened a new position in Greenhill & Co., Inc. worth $8.55M.
- Columbia Partners Investment Management's largest Q2 2014 buy was Greenhill & Co., Inc.: 173,566 shares worth $8.55M.
- Columbia Partners Investment Management added most to Visa in Q2 2014, an estimated $7.84M increase.
- Columbia Partners Investment Management's biggest Q2 2014 reduction was MasTec, cutting an estimated $16M.
- Columbia Partners Investment Management fully exited Rocket Fuel Inc. in Q2 2014, selling an estimated $11.1M.
- Columbia Partners Investment Management's ten largest holdings make up 17% of its $2.16B portfolio in Q2 2014.
- Columbia Partners Investment Management opened 65 new positions and closed 55 in Q2 2014.
- Columbia Partners Investment Management's portfolio value fell 5.7% quarter-over-quarter to $2.16B.
Based on Columbia Partners Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.